ES2772131T3 - Un nuevo proceso para la preparación de Febuxostat - Google Patents

Un nuevo proceso para la preparación de Febuxostat Download PDF

Info

Publication number
ES2772131T3
ES2772131T3 ES14750307T ES14750307T ES2772131T3 ES 2772131 T3 ES2772131 T3 ES 2772131T3 ES 14750307 T ES14750307 T ES 14750307T ES 14750307 T ES14750307 T ES 14750307T ES 2772131 T3 ES2772131 T3 ES 2772131T3
Authority
ES
Spain
Prior art keywords
group
compound
formula
copper
febuxostat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14750307T
Other languages
English (en)
Spanish (es)
Inventor
Theocharis Koftis
Efstratios Neokosmidis
Sakellarios Trakossas
Theodoros Panagiotidis
Thanos Andreou
Anastasia-Aikaterini Varvogli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmathen SA
Original Assignee
Pharmathen SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathen SA filed Critical Pharmathen SA
Application granted granted Critical
Publication of ES2772131T3 publication Critical patent/ES2772131T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
ES14750307T 2013-08-07 2014-07-30 Un nuevo proceso para la preparación de Febuxostat Active ES2772131T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2013002361 2013-08-07
PCT/EP2014/002079 WO2015018507A2 (en) 2013-08-07 2014-07-30 A novel process for the preparation of febuxostat

Publications (1)

Publication Number Publication Date
ES2772131T3 true ES2772131T3 (es) 2020-07-07

Family

ID=51302690

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14750307T Active ES2772131T3 (es) 2013-08-07 2014-07-30 Un nuevo proceso para la preparación de Febuxostat

Country Status (4)

Country Link
JP (2) JP6585044B2 (ja)
CN (1) CN105452228B (ja)
ES (1) ES2772131T3 (ja)
WO (1) WO2015018507A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108440443A (zh) * 2018-05-16 2018-08-24 无棣锐新医药化工有限公司 非布索坦中间体的制备方法
CN109503512B (zh) * 2018-12-28 2021-05-07 大连理工大学 一种非布司他及其中间体的合成方法
CN109503513B (zh) * 2018-12-29 2020-09-25 嘉实（湖南）医药科技有限公司 一种非布司他中间体的“一锅法”合成方法
CN113072519A (zh) * 2021-04-01 2021-07-06 福建海西新药创制有限公司 一种利用微反应装置连续生产非布司他的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122008000051I1 (de) 1990-11-30 2009-02-05 Teijin Ltd 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel
JP2706037B2 (ja) 1993-04-13 1998-01-28 帝人株式会社 シアノ化合物およびその製造方法
JP2834971B2 (ja) * 1993-05-25 1998-12-14 帝人株式会社 ２−（４−アルコキシ−３−シアノフェニル）チアゾール誘導体の製造法およびその新規製造中間体
JP3202607B2 (ja) * 1996-08-01 2001-08-27 帝人株式会社 ２−（４−アルコキシ−３−シアノフェニル）チアゾール誘導体の製造法
EP2786995A1 (en) * 2004-03-30 2014-10-08 Vertex Pharmaceuticals Incorporated Azaindoles useful as inhibitors of JAK and other protein kinases
CN101412700B (zh) * 2007-10-19 2011-06-08 上海医药工业研究院 非布司他的晶型及其制备方法
EP2266966A1 (en) 2009-06-11 2010-12-29 Chemo Ibérica, S.A. A process for the preparation of febuxostat
CN102079731A (zh) * 2009-11-26 2011-06-01 上海和臣医药工程有限公司 一种2-(3-氰基-4-(2-甲基丙氧基)苯基)-4-甲基-5-噻唑甲酸的合成方法
CN101723915B (zh) * 2009-12-25 2012-01-25 北京赛科药业有限责任公司 一种制备非布索坦中间体的方法
WO2011141933A2 (en) * 2010-05-12 2011-11-17 Msn Laboratories Limited Process for preparation of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid and its pharmaceutically acceptable salts
US20130303780A1 (en) * 2010-11-08 2013-11-14 Siva Rama Prasad Vellanki Process for the preparation of 2-arylthiazole derivatives

Also Published As

Publication number Publication date
CN105452228B (zh) 2018-10-09
WO2015018507A3 (en) 2015-10-22
CN105452228A (zh) 2016-03-30
JP2019194203A (ja) 2019-11-07
JP6585044B2 (ja) 2019-10-02
JP2017509581A (ja) 2017-04-06
WO2015018507A2 (en) 2015-02-12

Similar Documents

Publication Publication Date Title
CN108368132B (zh) 双（氟磺酰基）酰亚胺锂的新型制造方法
ES2772131T3 (es) Un nuevo proceso para la preparación de Febuxostat
US11713298B2 (en) Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
EP3421504B1 (en) Process for making sugammadex
JP2019131530A (ja) 硫酸エステルの生成方法
KR102266680B1 (ko) 벨리노스테트의 다형태 및 이의 제조 방법
JP2009502814A (ja) Ｎ置換イソチアゾリノン誘導体の製造
JP2015530985A5 (ja)
CN109369779B (zh) 一种他替瑞林的合成方法
ES2706755T3 (es) Procedimiento de preparación de bis(3-aminofenil) disulfuros y 3-aminotioles
CN105801459A (zh) 一锅法制备芳基磺酸三氟甲硫酯系列化合物的方法
US20070117982A1 (en) Method for producing 1,2-unsaturated azasteroids
ES2538090T3 (es) Proceso para la producción de una carbodiimida
EP3030551B1 (en) A novel process for the preparation of febuxostat
KR101557702B1 (ko) 미티글리니드 칼슘 이수화물의 제조방법
JP5663482B2 (ja) ピリミジニルアセトニトリル誘導体の製造方法及びその合成中間体
CN114685313A (zh) 一种肟菌酯的制备方法
WO2018149212A1 (zh) 一种吡啶环磺酰亚胺碱金属盐的制备方法
JP4500983B2 (ja) ６−アルコキシ−２−ナフタレンチオールおよびその製造方法
US20060252928A1 (en) Process for the preparation of cefoxitin
IL149063A (en) Process for the preparation of ariltriazolanones and their new intermediates
JP2008007501A (ja) メルカプト複素環化合物の製造方法
JP6336166B2 (ja) イミダフェナシンの新規中間体、その製造方法及びそれを用いたイミダフェナシンの製造方法
JP2006193480A (ja) １，３−ジベンジル−２−オキソイミダゾリジン−４，５−ジカルボン酸の製造方法
JP3558798B2 (ja) ヒドロキシアルキル（メタ）アクリレートのクロロホルメートの製造方法